STAT3 and breast carcinoma: Consistent with other findings that miR-34a significantly increased with the treatment of stattic (a small-molecule inhibitor of STAT3) [69], we found that depletion of STAT3 markedly attenuated the leptin-induced suppression of miR-34a in breast cancer cells (Figure 8G).